

Becton Dickinson announced a $19 billion investment in US manufacturing to secure the healthcare supply chain and achieve tariff relief.
You can purchase shares of Becton Dickinson (NYSE:BDX) through any online brokerage.
Other companies in Becton Dickinson’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Becton Dickinson has a consensus price target of $194.74.
The stock price for Becton Dickinson (NYSE: BDX) is $199.98 last updated November 2, 2026 at 4:03 PM EST.
There are no upcoming dividends for Becton Dickinson.
Becton Dickinson does not have any upcoming earnings scheduled.
There is no upcoming split for Becton Dickinson.
Becton Dickinson is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention...